50 related articles for article (PubMed ID: 29400012)
1. Comparison of surgical and oncologic outcomes in patients with clear cell ovarian carcinoma associated with and without endometriosis.
Charatsingha R; Hanamornroongruang S; Benjapibal M; Therasakvichya S; Jaishuen A; Chaopotong P; Srichaikul P; Jareemit N
Arch Gynecol Obstet; 2021 Dec; 304(6):1569-1576. PubMed ID: 34023979
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and prognosis of ovarian clear cell carcinoma: a 10-year retrospective study.
Zhu C; Zhu J; Qian L; Liu H; Shen Z; Wu D; Zhao W; Xiao W; Zhou Y
BMC Cancer; 2021 Mar; 21(1):322. PubMed ID: 33766002
[TBL] [Abstract][Full Text] [Related]
3. Exploration and prognostic analysis of two types of high-risk ovarian cancers: clear cell vs. serous carcinoma: a population-based study.
Liu T; Gao Y; Li S; Xu S
J Ovarian Res; 2024 Jun; 17(1):119. PubMed ID: 38824600
[TBL] [Abstract][Full Text] [Related]
4. Trends in survival of ovarian clear cell carcinoma patients from 2000 to 2015.
Tian BQ; Wang SW; Xu JY; Wu SG; Zhou J
Front Oncol; 2024; 14():1360663. PubMed ID: 38515571
[TBL] [Abstract][Full Text] [Related]
5. From clinical management to personalized medicine: novel therapeutic approaches for ovarian clear cell cancer.
Liu Z; Jing C; Kong F
J Ovarian Res; 2024 Feb; 17(1):39. PubMed ID: 38347608
[TBL] [Abstract][Full Text] [Related]
6. The impact of lymphadenectomy on ovarian clear cell carcinoma: a systematic review and meta-analysis.
Liu Y; Geng F; Zhang H; Xue J; Chu R
World J Surg Oncol; 2024 Jan; 22(1):37. PubMed ID: 38287354
[TBL] [Abstract][Full Text] [Related]
7. Nodal infiltration in endometrial cancer: a prediction model using best subset regression.
Matsumoto YK; Himoto Y; Nishio M; Kikkawa N; Otani S; Ito K; Yamanoi K; Kato T; Fujimoto K; Kurata Y; Moribata Y; Yoshida H; Minamiguchi S; Mandai M; Kido A; Nakamoto Y
Eur Radiol; 2024 May; 34(5):3375-3384. PubMed ID: 37882835
[TBL] [Abstract][Full Text] [Related]
8. Influence of lymphadenectomy on survival and recurrence in patients with early-stage epithelial ovarian cancer: a meta-analysis.
Yang C; Zhang T; Gong A; Shi C
BMC Womens Health; 2023 Sep; 23(1):474. PubMed ID: 37667358
[TBL] [Abstract][Full Text] [Related]
9. Developing and validating a prognostic nomogram for ovarian clear cell carcinoma patients: A retrospective comparison of lymph node staging schemes with competing risk analysis.
Li Y; Xiu L; Ma M; Seery S; Lou X; Li K; Wu Y; Liang S; Wu Y; Cui W
Front Oncol; 2022; 12():940601. PubMed ID: 36439411
[TBL] [Abstract][Full Text] [Related]
10. Differential roles of the Wip1-p38-p53 DNA damage response pathway in early/advanced-stage ovarian clear cell carcinomas.
Xu C; Minaguchi T; Qi N; Fujieda K; Suto A; Itagaki H; Shikama A; Tasaka N; Akiyama A; Nakao S; Ochi H; Satoh T
World J Surg Oncol; 2022 Apr; 20(1):139. PubMed ID: 35490254
[TBL] [Abstract][Full Text] [Related]
11. Unexpected malignancy at the time of hysterectomy performed for a benign indication: A retrospective review.
Elliott CG; Murji A; Matelski J; Adekola AB; Chrzanowski J; Shirreff L
PLoS One; 2022; 17(4):e0266338. PubMed ID: 35363824
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of the number of removed lymph nodes according to FIGO stage in ovarian clear cell carcinoma.
Tamura K; Takei Y; Matsubara S; Takahashi S; Taneichi A; Takahashi Y; Yoshiba T; Koyanagi T; Saga Y; Fujiwara H
Mol Clin Oncol; 2021 Dec; 15(6):263. PubMed ID: 34777799
[TBL] [Abstract][Full Text] [Related]
13. Updates of Pathogenesis, Diagnostic and Therapeutic Perspectives for Ovarian Clear Cell Carcinoma.
Zhu C; Xu Z; Zhang T; Qian L; Xiao W; Wei H; Jin T; Zhou Y
J Cancer; 2021; 12(8):2295-2316. PubMed ID: 33758607
[TBL] [Abstract][Full Text] [Related]
14. Metastasis of Ovarian Cancer to Breast: A Case Report and Review of Imaging Manifestations.
Wang J; Wang B
Cancer Manag Res; 2020; 12():13015-13021. PubMed ID: 33376395
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma.
Chen Q; Wang S; Lang JH
J Ovarian Res; 2020 Oct; 13(1):123. PubMed ID: 33069259
[TBL] [Abstract][Full Text] [Related]
16. Incidence and predictors of peritoneal metastases of gynecological origin: a population-based study in the Netherlands.
Burg L; Timmermans M; van der Aa M; Boll D; Rovers K; de Hingh I; van Altena A
J Gynecol Oncol; 2020 Sep; 31(5):e58. PubMed ID: 32808491
[TBL] [Abstract][Full Text] [Related]
17. Rethinking of treatment strategies and clinical management in ovarian clear cell carcinoma.
Takahashi K; Takenaka M; Kawabata A; Yanaihara N; Okamoto A
Int J Clin Oncol; 2020 Mar; 25(3):425-431. PubMed ID: 31989349
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic significance of full lymphadenectomy in early-stage ovarian clear cell carcinoma.
Yamazaki H; Todo Y; Shimada C; Takeshita S; Minobe S; Okamoto K; Yamashiro K; Kato H
J Gynecol Oncol; 2018 Mar; 29(2):e19. PubMed ID: 29400012
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
